Ignite Creation Date:
2025-12-24 @ 10:08 PM
Ignite Modification Date:
2026-01-05 @ 5:46 PM
Study NCT ID:
NCT03350035
Status:
COMPLETED
Last Update Posted:
2023-03-09
First Post:
2017-11-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Intravenous Ganaxolone as Adjunctive Therapy to Treat Subjects With Status Epilepticus
Sponsor:
Marinus Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-02-19
Start Date Type:
ACTUAL
Primary Completion Date:
2019-09-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-09-18
Completion Date Type:
ACTUAL
First Submit Date:
2017-11-17
First Submit QC Date:
None
Study First Post Date:
2017-11-22
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2022-09-28
Results First Submit QC Date:
None
Results First Post Date:
2022-12-15
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
2022-12-15
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2023-03-08
Last Update Post Date:
2023-03-09
Last Update Post Date Type:
ACTUAL